Analyzing the genetic factors of hidradenitis suppurativa
Whole genome sequencing analysis of hidradenitis suppurativa
This study is looking at how genetics might play a role in hidradenitis suppurativa, a painful skin condition, by comparing samples from African American, Hispanic/Latino, and White patients to understand why the disease affects different groups in different ways, and your participation could help us learn more about it!
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health + Michigan State University Health Sciences NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10981631 on NIH RePORTER |
What this research studies
This research investigates hidradenitis suppurativa (HS), a chronic skin condition that causes painful nodules and abscesses. By utilizing whole genome sequencing, the study aims to identify genetic variations that contribute to the risk of HS, particularly focusing on differences among African American, Hispanic/Latino, and White patients. The research will explore how these genetic factors may explain the disparities in disease prevalence and severity across different racial groups. Patients may be asked to provide genetic samples and health information to help uncover these associations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with hidradenitis suppurativa, particularly those from African American and Hispanic/Latino backgrounds.
Not a fit: Patients who do not have hidradenitis suppurativa or those outside the specified racial groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients suffering from hidradenitis suppurativa.
How similar studies have performed: Previous research has shown promising results in understanding genetic contributions to other chronic conditions, suggesting potential for success in this novel approach.
Where this research is happening
East Lansing, United States
- Henry Ford Health + Michigan State University Health Sciences — East Lansing, United States (Active)
Researchers
- Principal investigator: Mi, Qing-Sheng — Henry Ford Health + Michigan State University Health Sciences
- Study coordinator: Mi, Qing-Sheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.